Patterns of Fatigue in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs

被引：0
|
作者：
Freites Nunez, Dalifer [1 ]
Leon, Leticia [2 ]
Redondo, Marta [3 ]
Vadillo Font, Cristina [1 ]
Lois, Pia [1 ]
Mucientes Ruiz, Arkaitz [1 ]
Rodriguez-Rodriguez, Luis [2 ]
Fernandez Gutierrez, Benjamin [1 ]
Jover Jover, Juan Angel [1 ]
Abasolo Alcazar, Lydia [1 ]
机构：
[1] Hosp Clin San Carlos, Madrid, Spain
[2] Fdn Invest Biomed, Madrid, Spain
[3] Univ Camilo Jose Ceja, Madrid, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1334
引用
收藏
页数：3
相关论文
共 50 条
  • [21] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
    Smolen, Josef S.
    Landewe, Robert B. M.
    Bergstra, Sytske Anne
    Kerschbaumer, Andreas
    Sepriano, Alexandre
    Aletaha, Daniel
    Caporali, Roberto
    Edwards, Christopher John
    Hyrich, Kimme L.
    Pope, Janet E.
    de Souza, Savia
    Stamm, Tanja A.
    Takeuchi, Tsutomu
    Verschueren, Patrick
    Winthrop, Kevin L.
    Balsa, Alejandro
    Bathon, Joan M.
    Buch, Maya H.
    Burmester, Gerd R.
    Buttgereit, Frank
    Cardiel, Mario Humberto
    Chatzidionysiou, Katerina
    Codreanu, Catalin
    Cutolo, Maurizio
    den Broeder, Alfons A.
    El Aoufy, Khadija
    Finckh, Axel
    Fonseca, Joao Eurico
    Gottenberg, Jacques-Eric
    Haavardsholm, Espen A.
    Iagnocco, Annamaria
    Lauper, Kim
    Li, Zhanguo
    McInnes, Iain B.
    Mysler, Eduardo F.
    Nash, Peter
    Poor, Gyula
    Ristic, Gorica G.
    Rivellese, Felice
    Rubbert-Roth, Andrea
    Schulze-Koops, Hendrik
    Stoilov, Nikolay
    Strangfeld, Anja
    van der Helm-van Mil, Annette
    van Duuren, Elsa
    Vliet Vlieland, Theodora P. M.
    Westhovens, Rene
    van der Heijde, Desiree
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (01) : 3 - 18
  • [22] Treatment failure with disease-modifying antirheumatic drugs in rheumatoid arthritis patients
    Mittal, Niti
    Mittal, Rakesh
    Sharma, Aman
    Jose, Vinu
    Wanchu, Ajay
    Singh, Surjit
    SINGAPORE MEDICAL JOURNAL, 2012, 53 (08) : 532 - 536
  • [23] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
    Smolen, Josef S.
    Landewe, Robert B. M.
    Bijlsma, Johannes W. J.
    Burmester, Gerd R.
    Dougados, Maxime
    Kerschbaumer, Andreas
    McInnes, Iain B.
    Sepriano, Alexandre
    van Vollenhoven, Ronald F.
    de Wit, Maarten
    Aletaha, Daniel
    Aringer, Martin
    Askling, John
    Balsa, Alejandro
    Boers, Maarten
    den Broeder, Alfons A.
    Buch, Maya H.
    Buttgereit, Frank
    Caporali, Roberto
    Cardiel, Mario Humberto
    De Cock, Diederik
    Codreanu, Catalin
    Cutolo, Maurizio
    Edwards, Christopher John
    van Eijk-Hustings, Yvonne
    Emery, Paul
    Finckh, Axel
    Gossec, Laure
    Gottenberg, Jacques-Eric
    Hetland, Merete Lund
    Huizinga, Tom W. J.
    Koloumas, Marios
    Li, Zhanguo
    Mariette, Xavier
    Mueller-Ladner, Ulf
    Mysler, Eduardo F.
    da Silva, Jose A. P.
    Poor, Gyula
    Pope, Janet E.
    Rubbert-Roth, Andrea
    Ruyssen-Witrand, Adeline
    Saag, Kenneth G.
    Strangfeld, Anja
    Takeuchi, Tsutomu
    Voshaar, Marieke
    Westhovens, Rene
    van der Heijde, Desiree
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (06) : 685 - 699
  • [24] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
    Smolen, Josef S.
    Landewe, Robert
    Bijlsma, Johannes
    Burmester, Gerd
    Chatzidionysiou, Katerina
    Dougados, Maxime
    Nam, Jackie
    Ramiro, Sofia
    Voshaar, Marieke
    van Vollenhoven, Ronald
    Aletaha, Daniel
    Aringer, Martin
    Boers, Maarten
    Buckley, Chris D.
    Buttgereit, Frank
    Bykerk, Vivian
    Cardiel, Mario
    Combe, Bernard
    Cutolo, Maurizio
    van Eijk-Hustings, Yvonne
    Emery, Paul
    Finckh, Axel
    Gabay, Cem
    Gomez-Reino, Juan
    Gossec, Laure
    Gottenberg, Jacques-Eric
    Hazes, Johanna M. W.
    Huizinga, Tom
    Jani, Meghna
    Karateev, Dmitry
    Kouloumas, Marios
    Kvien, Tore
    Li, Zhanguo
    Mariette, Xavier
    McInnes, Iain
    Mysler, Eduardo
    Nash, Peter
    Pavelka, Karel
    Poor, Gyula
    Richez, Christophe
    van Riel, Piet
    Rubbert-Roth, Andrea
    Saag, Kenneth
    da Silva, Jose
    Stamm, Tanja
    Takeuchi, Tsutomu
    Westhovens, Rene
    de Wit, Maarten
    van der Heijde, Desiree
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (06) : 960 - 977
  • [25] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
    Smolen, Josef S.
    Landewe, Robert
    Breedveld, Ferdinand C.
    Buch, Maya
    Burmester, Gerd
    Dougados, Maxime
    Emery, Paul
    Gaujoux-Viala, Cecile
    Gossec, Laure
    Nam, Jackie
    Ramiro, Sofia
    Winthrop, Kevin
    de Wit, Maarten
    Aletaha, Daniel
    Betteridge, Neil
    Bijlsma, Johannes W. J.
    Boers, Maarten
    Buttgereit, Frank
    Combe, Bernard
    Cutolo, Maurizio
    Damjanov, Nemanja
    Hazes, Johanna M. W.
    Kouloumas, Marios
    Kvien, Tore K.
    Mariette, Xavier
    Pavelka, Karel
    van Riel, Piet L. C. M.
    Rubbert-Roth, Andrea
    Scholte-Voshaar, Marieke
    Scott, David L.
    Sokka-Isler, Tuulikki
    Wong, John B.
    van der Heijde, Desiree
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (03) : 492 - 509
  • [26] Cardiovascular risk in rheumatoid arthritis patients treated with targeted synthetic and biological disease-modifying antirheumatic drugs: A multi-centre cohort study
    Tong, Xinning
    Shen, Chin-Yao
    Jeon, Ha-Lim
    Li, Yihua
    Shin, Ju-Young
    Chan, Shirley C. W.
    Yiu, Kai Hang
    Pratt, Nicole L.
    Ward, Michael
    Lau, Chak Sing
    Wong, Ian C. K.
    Li, Xue
    Lai, Edward Chia-Cheng
    JOURNAL OF INTERNAL MEDICINE, 2023, 294 (03) : 314 - 325
  • [27] Discontinuation of Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Excellent Disease Control
    Lillegraven, Siri
    Sundlisaeter, Nina Paulshus
    Aga, Anna-Birgitte
    Sexton, Joseph
    Solomon, Daniel H.
    van der Heijde, Desiree
    Haavardsholm, Espen A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (12): : 1024 - 1026
  • [28] Socioeconomic impact of treatment with biological disease-modifying antirheumatic drugs in Japanese patients with rheumatoid arthritis
    Yamanaka, Hisashi
    Kishimoto, Mitsumasa
    Nishijima, Nobuo
    Yamashita, Katsuhisa
    Matsushima, Junnosuke
    O'Brien, Jacqueline
    Blachley, Taylor
    Eliot, Melissa
    Margolin, Zachary
    Dave, Swapna S.
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2023, 34 (01) : 27 - 36
  • [29] Association between malignancy and methotrexate and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
    Inose, Ryo
    Hashimoto, Natsue
    Hosomi, Kouichi
    Yokoyama, Satoshi
    Takada, Mitsutaka
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (03) : 131 - 138
  • [30] PREFERENCES OF EUROPEAN RHEUMATOLOGISTS ON THE DISCONTINUATION OF BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Schlager, Lukas
    Loiskandl, Michaela
    Aletaha, Daniel
    Radner, Helga
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1152 - 1153
12345